Sumitomo Dainippon reported JPY23.12B in Cash and Equivalent for its fiscal quarter ending in March of 2025.


Cash And Equivalent Change Date
Astellas Pharma JPY 188.37B 8.51B Mar/2025
Chugai Pharma JPY 497.09B 73.67B Jun/2025
Daiichi Sankyo JPY 639.84B 42.31B Mar/2025
Eisai JPY 285.38B 19.82B Jun/2025
Kyowa Hakko Kirin JPY 214.37B 30.31B Mar/2025
M3 JPY 134.93B 11.23B Mar/2025
Otsuka Holdings JPY 407.5B 18.68B Mar/2025
Shionogi JPY 254.83B 119.97B Jun/2025
Sumitomo JPY 582.24B 125.33B Mar/2025
Sumitomo Dainippon JPY 23.12B 62.28B Mar/2025
Takeda JPY 350.01B 35.11B Jun/2025
Terumo JPY 204.29B 17.58B Jun/2025